Social Cognition
27
4
5
17
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 27 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
12%
2 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (27)
Social Cognition in Patients With Amyotrophic Lateral Sclerosis
Social COgnition Screening
The Bucharest Early Intervention Project
Facial Emotion Recognition in Patients With Euthymic Bipolar Disorder I and II
Losartan and Social Processing
MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD
The Effects of Executive Functions and Social Cognition on Mental Health
Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders
Neuropsychological Assessment of Children and Adolescents With Turner Syndrome
Study of Social Cognition Processes With Multimodal MRI on Healthy Adult Patients.
Online TP (Training Program) on SC (Social Cognition) for Schizophrenia
Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia
Effects of tDCS on Social Cognition in Aging
Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers
The German Version of the Awareness of Social Inference Test
Evaluation and Neural Basis of Communication in Patients With Multiple Sclerosis
Adult Study Oxytocin - Behavioral
Oxytocin and Social Cognition in Schizophrenia
Oxytocin, Emotions and Mirror Neurons
Adult Study Oxytocin - fMRI